Tex. Health & Safety Code § 491.052 · Subchapter B. ELIGIBLE PATIENT ACCESS TO INVESTIGATIONAL SUN PROTECTION PRODUCTS
INFORMED CONSENT.
Text — Current through the 89th 2nd Called Legislative Session, 2025
(a) Before recommending or prescribing an investigational sun protection product, a physician must require an eligible patient to sign a written informed consent form.
(b) If the patient is a minor or lacks the mental capacity to provide informed consent, a parent or legal guardian may provide informed consent on the patient's behalf.
(c) The Texas Medical Board by rule may adopt a form for the informed consent required under this section.
Notes and commentary — not statutory text
History
Added by Acts 2025, 89th Leg., R.S., Ch. 352 (S.B. 670), Sec. 2, eff. June 20, 2025.
Source of truth
- Edition
- Current through the 89th 2nd Called Legislative Session, 2025
- Official file
- https://statutes.capitol.texas.gov/Docs/HS/htm/HS.491.V2.htm
- Text hash
- sha256 9ecac4bc21c23d8d1b825997408d58c25fee57e3944d5f1a1d2ff5921cd61503
- Composed by
- compose_tx.py 2026-10-05: the Legislative Council's chapter files read in document order; verify_tx.py's independent reading (lxml DOM walk) agrees character for character
- the Legislature enacted more than one unit numbered 491.052; this is the one the Council prints in hs.491.v2.htm
Procedural information only. Not legal advice and not a substitute for the advice of an attorney. Confirm the current text with the official publisher before relying on it.